Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial.
about
Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from a phase 3 trial (MPACT).Systemic Combination Chemotherapy in Elderly Pancreatic Cancer: a Review.Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directionsResponse to Drs Von Hoff and RenschlerCross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer.From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer.Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer.
P2860
Q36171310-5C1DB65B-8488-46F1-B30E-EC063831C04AQ38902171-2494ED4B-3442-418F-BCED-7147F7F7ECC3Q41608480-9D04A908-4073-428F-AF2F-5D49BED9FDE5Q42227453-05DCDFD8-528A-4C6F-9DB2-F83ACDE075FCQ42361052-641CB141-7B1E-4C7E-8286-6E5F5AE02210Q55026515-32B722D0-2ABF-4703-AA01-8B4FA9E74F4CQ55364548-1AE392B5-3EE7-4024-BAE1-A8DAEAD259CB
P2860
Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Dose modification and efficacy ...... cancer: phase III MPACT trial.
@ast
Dose modification and efficacy ...... cancer: phase III MPACT trial.
@en
type
label
Dose modification and efficacy ...... cancer: phase III MPACT trial.
@ast
Dose modification and efficacy ...... cancer: phase III MPACT trial.
@en
prefLabel
Dose modification and efficacy ...... cancer: phase III MPACT trial.
@ast
Dose modification and efficacy ...... cancer: phase III MPACT trial.
@en
P2093
P2860
P356
P1476
Dose modification and efficacy ...... cancer: phase III MPACT trial.
@en
P2093
Alfredo Romano
Daniel D Von Hoff
David Goldstein
Desmond McGovern
Malcolm Moore
Ramesh K Ramanathan
Teresa Macarulla
Volker Kunzmann
Werner Scheithauer
P2860
P304
P356
10.21037/JGO.2016.01.03
P577
2016-06-01T00:00:00Z